3M Co
MMMNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 13/3042% above fair value
$178.36+4.02 (+2.31%)
Close on Nov 2, 2026Market cap $91.98BP/E 31.7Yield 1.64%
3M Research & Development Expense by Year
Research & Development Expense (Direct R&D Component, $M) ($M)
3M Research & Development Expense: $700M in 2024, unchanged from a year earlier. That is the lowest of the 9 years on record here. No newer figure appears in the documents we track.
Latest, 2024
700
Period ended Dec 31, 2024
Change on a year earlier
0.0%
700 in 2023
History
9 years
Since 2016
Sources
7
Documents cited below
Where the 2024 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Research & Development Expense (Direct R&D Component, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| 2024 | Dec 31, 2024 | 700 | 0.0% | SEC Form 10-K (filed 2025-02-05) ↗ |
| 2023 | Dec 31, 2023 | 700 | -12.5% | SEC Form 10-K (filed 2025-02-05) ↗ |
| 2022 | Dec 31, 2022 | 800 | -33.3% | SEC Form 10-K (filed 2025-02-05) ↗ |
| 2021 | Dec 31, 2021 | 1,200 | +9.1% | SEC Form 10-K (filed 2024-02-07) ↗ |
| 2020 | Dec 31, 2020 | 1,100 | -12.2% | SEC Form 10-K (filed 2023-02-08) ↗ |
| 2019 | Dec 31, 2019 | 1,253 | 0.0% | SEC Form 10-K (filed 2022-02-09) ↗ |
| 2018 | Dec 31, 2018 | 1,253 | -7.3% | SEC Form 10-K (filed 2021-02-04) ↗ |
| 2017 | Dec 31, 2017 | 1,352 | +8.3% | SEC Form 10-K (filed 2020-02-06) ↗ |
| 2016 | Dec 31, 2016 | 1,248 | – | SEC Form 10-K (filed 2019-02-07) ↗ |
Cite this data
StockData. (2026). 3M Research & Development Expense ($M), annual 2016–2024 [Data set]. Compiled from 3M SEC filings and investor materials. https://stockdatahq.com/stocks/mmm/kpis/inn-rd-usgaap
See every metric in the 3M KPI table. Data updated Nov 2, 2026.